Cost of medication and stigma leading asthma sufferers to risk health

Cost of medication and stigma leading asthma sufferers to risk health
Photo courtesy of Asthma UK

The high cost of medication, stigmatisation and poor acceptance of their condition are causing young adults to take a dangerous approach to managing their asthma, according to new research published today in the journal BMJ Open.

In the UK 5.4 million people are currently receiving treatment for : 1.1 million children (one in 11) and 4.3 million adults (one in 12). There were 1,131 deaths from asthma in the UK in 2009. Most asthma deaths are preventable.

Despite the availability of effective treatments, poor asthma control is common.

The overuse of short-acting bronchodilators ("quick-acting" inhalers, usually blue, which relieve acute ) is a marker of poor asthma control and is linked to increased risk of and death from asthma.

Regular use of low dose anti-inflammatory inhalers (preventer inhalers, usually brown) are fundamental to successfully controlling asthma, and preventing asthma symptoms.

In this study, led by Queen Mary, University of London, researchers looked at why (20yrs -32yrs) overuse short-acting bronchodilators. The researchers interviewed 21 young adults from the same urban general practice who were classed as either high users (12) or low users (nine) of short-acting bronchodilators as judged by their number of prescriptions. They found:

  • Cost was seen as a major disincentive to obtaining
  • High-users were more likely to express anger or resentment at their condition
  • High-users often reported poor control of their asthma symptoms
  • was common, with inhalers described as something "to hide in a bag"
Chris Griffiths, Professor of Primary Care at Queen Mary, who led the research said: "Relying on short-acting bronchodilators – 'my blue () takes a battering' as one patient put it – is not a safe way to manage asthma and individuals taking this approach are putting their lives and health at risk.

"Our findings suggest a number of possible strategies to support people to manage their condition better. Providing free asthma medication, particularly to those on low incomes, could help boost the numbers using preventive medication. Better education, particularly at the time of diagnosis, could help people accept and adapt to their illness, while reducing stigmatisation might mean people feel more comfortable about using their inhalers in public."

Emily Humphreys, Head of Policy and Public Affairs at Asthma UK, said: "Over-reliance on reliever asthma medicines instead of preventers puts people at greater risk of a potentially fatal asthma attack, so this study is really important in highlighting some of the reasons behind it.

"It's telling that young people felt the costs of prescriptions were such a major barrier to taking the right medicines at the right time and we're keen to see the introduction of free prescriptions for long-term conditions so that young people with asthma would no longer face the dilemma of which medicine to buy when they can only afford one.

"In the meantime it is absolutely crucial that healthcare professionals explain how medicines work, particularly when younger people are diagnosed with asthma, to ensure that they understand how to manage their condition."

More information: bmjopen.bmj.com/content/3/2/e002247.abstract

add to favorites email to friend print save as pdf

Related Stories

Poor asthma control prevalent in the united states

Feb 28, 2012

(HealthDay) -- Many patients with asthma who do not use controller medications have persistent disease, and among those patients who do use controller medications, few have well-controlled disease, according ...

Mold linked to asthma

Sep 05, 2007

A Cardiff University study has found that removing indoor mold improves the symptoms of people with asthma.

Recommended for you

Atypical antipsychotics up renal injury risk in seniors

10 hours ago

(HealthDay)—Use of atypical antipsychotic drugs is associated with increased risk of acute kidney injury (AKI) in older adults, according to research published in the Aug. 19 issue of the Annals of Internal Me ...

User comments